Announcement

Collapse
No announcement yet.

Starts next week vaccination against influenza A (H1N1) in India

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Starts next week vaccination against influenza A (H1N1) in India

    Noticias de lo que pasa en Latinoamérica y del Mundo, desarrolladas minuto a minuto desde las redacciones y corresponsalías de Prensa Latina.


    Starts next week vaccination against influenza A (H1N1) in India
    thursday, 04 of 2010 of marzo

    04 of March 2010, 00:25New Delhi, Mar 4 (Prensa Latina) The mass vaccination against influenza A (H1N1) will start in India next week after a batch of one million 500 thousand doses, acquired by the government, passed safety tests, reported Today an official source.

    The analysis showed that the vaccines are safe. Vaccination should start next week, ahead of the director of the State Agency for Control of Drugs (DCGI, for its acronym in English), Surinder Singh was quoted Thursday by The Times of India.

    According to the source, one million doses will be delivered to the hospitals run by the government, to be applied to health workers and all staff at risk of contracting the disease.

    The rest will be to vaccinate members of the armed forces, the newspaper said.

    The doses were purchased from the French laboratory Sanofi Pasteur, pending the disposal of the first vaccine produced in India, which is expected to be ready by mid May.

    At least four local pharmaceutical companies are locked in product development, it was announced that would cost three to five dollars per dose, compared with nine and $ 15 it costs in other countries.

    According to the latest report from the Ministry of Health in India thousand 383 people have died from the virus of influenza A (H1N1) since the disease was detected in the country in May 2009.

    Official figures compiled yesterday also show that 29 thousand 744 others have contracted the disease.

    lgo / nm

  • #2
    Re: Starts next week vaccination against influenza A (H1N1) in India

    Finally the much talked about vaccines for H1N1 are here in India and the mass vaccination against this deadly disease is expected to begin next week. Indian Government has imported 1.5 million doses of vaccines from Sanofi Pasteur, the vaccines division of Sanofi Aventis Group

    The vaccine doses have passed the safety tests successfully. Reports of Clinical bridge study were submitted by Sanofi Pasteur to the Drug Controller General of India on Wednesday. The study was conducted at Kalavati Saran Hospital in Delhi and Bharatiya Vidyapith in Pune on 100 adults.

    Steps have been taken to assure the safety of these vaccines such as testing the vaccine profile twice- first for seven days and then for 21 days. It is believed
    that no vaccine is safe for everyone and may lead to side effects in some people. Dr Singh said, "We didn't want it to cause side-effects like the Guillain-Barri syndrome (GBS) -- a rare disease in which the body damages its own nerve cells, causing muscle weakness and sometimes paralysis. The company will, however, continue to check the vaccine's immunogenicity results, which will come in six weeks time."

    Throwing more light on the issue, DCGI Dr Surinder Singh said, "The trials of the vaccine have proven its safety profile. By Friday, we will vet the results and give its clearance for use on humans in India. By next week, the vaccination should begin."

    Going by the information provided by Union health ministry officials, 10 lakh doses of the vaccine will be sent to all Central government hospitals so that the vaccine is administered on all front line health workers and those at the highest risk of getting infected.

    Rest of the doses would be given to the armed forces while some would be retained by the ministry.

    Meanwhile Indian based Pharma companies are in the process of producing the vaccine indigenously. Companies such and Ahmedabad-based Zydus Cadila, Serum Institute, Bharat Biotech International and Panacea Biotec are engaged in this process. These vaccines are expected to be priced between Rs 150-200 and would be administered as a single dose. Dr Singh said, "If all goes well with the Indian vaccines and they prove safe and effective, they should be available commercially between April 15 and 30.

    "Don't get the flu. Don't spread the flu. Get Vaccinated."

    Comment

    Working...
    X